[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Asia-Pacific Bio-protein Drug Market Report 2018

January 2018 | 116 pages | ID: A97C3790AF4EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Bio-protein Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Bio-protein Drug for these regions, from 2012 to 2022 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Bio-protein Drug market competition by top manufacturers/players, with Bio-protein Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Abbott Laboratories
  • Bayer AG
  • Eli Lilly and Company
  • Amgen Inc.
  • Biocon Ltd.
  • Dr. Reddy’s Laboratories
  • Roche
  • Fresenius kabi
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck
  • Novartis AG
  • Panacea Biotec
  • ProBioGen AG
  • Sanofi
  • Reliance Life Science Pvt. Ltd.
On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
  • Monoclonal Antibodies
  • Therapeutic Proteins
  • Vaccines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Pharma and Biotech Companies
  • CROs
  • Academics
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Bio-protein Drug Market Report 2017

1 BIO-PROTEIN DRUG OVERVIEW

1.1 Product Overview and Scope of Bio-protein Drug
1.2 Classification of Bio-protein Drug by Product Category
  1.2.1 Asia-Pacific Bio-protein Drug Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Bio-protein Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Monoclonal Antibodies
  1.2.4 Therapeutic Proteins
  1.2.5 Vaccines
1.3 Asia-Pacific Bio-protein Drug Market by Application/End Users
  1.3.1 Asia-Pacific Bio-protein Drug Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Pharma and Biotech Companies
  1.3.3 CROs
  1.3.4 Academics
1.4 Asia-Pacific Bio-protein Drug Market by Region
  1.4.1 Asia-Pacific Bio-protein Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Bio-protein Drug (2012-2022)
  1.5.1 Asia-Pacific Bio-protein Drug Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Bio-protein Drug Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC BIO-PROTEIN DRUG COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Bio-protein Drug Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Bio-protein Drug Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Bio-protein Drug Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Bio-protein Drug (Volume and Value) by Type
  2.2.1 Asia-Pacific Bio-protein Drug Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Bio-protein Drug Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Bio-protein Drug (Volume) by Application
2.4 Asia-Pacific Bio-protein Drug (Volume and Value) by Region
  2.4.1 Asia-Pacific Bio-protein Drug Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Bio-protein Drug Revenue and Market Share by Region (2012-2017)

3 CHINA BIO-PROTEIN DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 China Bio-protein Drug Sales and Value (2012-2017)
  3.1.1 China Bio-protein Drug Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Bio-protein Drug Revenue and Growth Rate (2012-2017)
  3.1.3 China Bio-protein Drug Sales Price Trend (2012-2017)
3.2 China Bio-protein Drug Sales Volume and Market Share by Type
3.3 China Bio-protein Drug Sales Volume and Market Share by Application

4 JAPAN BIO-PROTEIN DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Bio-protein Drug Sales and Value (2012-2017)
  4.1.1 Japan Bio-protein Drug Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Bio-protein Drug Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Bio-protein Drug Sales Price Trend (2012-2017)
4.2 Japan Bio-protein Drug Sales Volume and Market Share by Type
4.3 Japan Bio-protein Drug Sales Volume and Market Share by Application

5 SOUTH KOREA BIO-PROTEIN DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Bio-protein Drug Sales and Value (2012-2017)
  5.1.1 South Korea Bio-protein Drug Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Bio-protein Drug Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Bio-protein Drug Sales Price Trend (2012-2017)
5.2 South Korea Bio-protein Drug Sales Volume and Market Share by Type
5.3 South Korea Bio-protein Drug Sales Volume and Market Share by Application

6 TAIWAN BIO-PROTEIN DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Bio-protein Drug Sales and Value (2012-2017)
  6.1.1 Taiwan Bio-protein Drug Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Bio-protein Drug Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Bio-protein Drug Sales Price Trend (2012-2017)
6.2 Taiwan Bio-protein Drug Sales Volume and Market Share by Type
6.3 Taiwan Bio-protein Drug Sales Volume and Market Share by Application

7 INDIA BIO-PROTEIN DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 India Bio-protein Drug Sales and Value (2012-2017)
  7.1.1 India Bio-protein Drug Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Bio-protein Drug Revenue and Growth Rate (2012-2017)
  7.1.3 India Bio-protein Drug Sales Price Trend (2012-2017)
7.2 India Bio-protein Drug Sales Volume and Market Share by Type
7.3 India Bio-protein Drug Sales Volume and Market Share by Application

8 SOUTHEAST ASIA BIO-PROTEIN DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Bio-protein Drug Sales and Value (2012-2017)
  8.1.1 Southeast Asia Bio-protein Drug Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Bio-protein Drug Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Bio-protein Drug Sales Price Trend (2012-2017)
8.2 Southeast Asia Bio-protein Drug Sales Volume and Market Share by Type
8.3 Southeast Asia Bio-protein Drug Sales Volume and Market Share by Application

9 AUSTRALIA BIO-PROTEIN DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Bio-protein Drug Sales and Value (2012-2017)
  9.1.1 Australia Bio-protein Drug Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Bio-protein Drug Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Bio-protein Drug Sales Price Trend (2012-2017)
9.2 Australia Bio-protein Drug Sales Volume and Market Share by Type
9.3 Australia Bio-protein Drug Sales Volume and Market Share by Application

10 ASIA-PACIFIC BIO-PROTEIN DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Abbott Laboratories
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Bio-protein Drug Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Abbott Laboratories Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Bayer AG
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Bio-protein Drug Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Bayer AG Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Eli Lilly and Company
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Bio-protein Drug Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Eli Lilly and Company Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Amgen Inc.
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Bio-protein Drug Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Amgen Inc. Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Biocon Ltd.
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Bio-protein Drug Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Biocon Ltd. Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Dr. Reddy’s Laboratories
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Bio-protein Drug Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Dr. Reddy’s Laboratories Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Roche
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Bio-protein Drug Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Roche Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Fresenius kabi
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Bio-protein Drug Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Fresenius kabi Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 GlaxoSmithKline
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Bio-protein Drug Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 GlaxoSmithKline Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Johnson & Johnson
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Bio-protein Drug Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Johnson & Johnson Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview
10.11 Merck
10.12 Novartis AG
10.13 Panacea Biotec
10.14 ProBioGen AG
10.15 Sanofi
10.16 Reliance Life Science Pvt. Ltd.

11 BIO-PROTEIN DRUG MANUFACTURING COST ANALYSIS

11.1 Bio-protein Drug Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Bio-protein Drug

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Bio-protein Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Bio-protein Drug Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC BIO-PROTEIN DRUG MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Bio-protein Drug Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Bio-protein Drug Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Bio-protein Drug Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Bio-protein Drug Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Bio-protein Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Bio-protein Drug Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Bio-protein Drug Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Bio-protein Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Bio-protein Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Bio-protein Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Bio-protein Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Bio-protein Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Bio-protein Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Bio-protein Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Bio-protein Drug Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Bio-protein Drug Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Bio-protein Drug Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Bio-protein Drug Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Bio-protein Drug Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Bio-protein Drug
Figure Asia-Pacific Bio-protein Drug Sales Volume (K Units) by Type (2012-2022)
Figure Asia-Pacific Bio-protein Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Monoclonal Antibodies Product Picture
Figure Therapeutic Proteins Product Picture
Figure Vaccines Product Picture
Figure Asia-Pacific Bio-protein Drug Sales (K Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Bio-protein Drug by Application in 2016
Figure Pharma and Biotech Companies Examples
Table Key Downstream Customer in Pharma and Biotech Companies
Figure CROs Examples
Table Key Downstream Customer in CROs
Figure Academics Examples
Table Key Downstream Customer in Academics
Figure Asia-Pacific Bio-protein Drug Market Size (Million USD) by Region (2012-2022)
Figure China Bio-protein Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Bio-protein Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Bio-protein Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Bio-protein Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Bio-protein Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Bio-protein Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Bio-protein Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Bio-protein Drug Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Asia-Pacific Bio-protein Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Bio-protein Drug Market Major Players Product Sales Volume (K Units)(2012-2017)
Table Asia-Pacific Bio-protein Drug Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Bio-protein Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Bio-protein Drug Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Bio-protein Drug Sales Share by Players/Suppliers
Figure Asia-Pacific Bio-protein Drug Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Bio-protein Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Bio-protein Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Bio-protein Drug Revenue Share by Players
Figure 2017 Asia-Pacific Bio-protein Drug Revenue Share by Players
Table Asia-Pacific Bio-protein Drug Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Bio-protein Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Bio-protein Drug by Type (2012-2017)
Figure Asia-Pacific Bio-protein Drug Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Bio-protein Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Bio-protein Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Bio-protein Drug by Type (2012-2017)
Figure Asia-Pacific Bio-protein Drug Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Bio-protein Drug Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Asia-Pacific Bio-protein Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Bio-protein Drug by Region (2012-2017)
Figure Asia-Pacific Bio-protein Drug Sales Market Share by Region in 2016
Table Asia-Pacific Bio-protein Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Bio-protein Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Bio-protein Drug by Region (2012-2017)
Figure Asia-Pacific Bio-protein Drug Revenue Market Share by Region in 2016
Table Asia-Pacific Bio-protein Drug Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific Bio-protein Drug Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Bio-protein Drug Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Bio-protein Drug Sales Market Share by Application (2012-2017)
Figure China Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)
Figure China Bio-protein Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Bio-protein Drug Sales Price (USD/Unit) Trend (2012-2017)
Table China Bio-protein Drug Sales Volume (K Units) by Type (2012-2017)
Table China Bio-protein Drug Sales Volume Market Share by Type (2012-2017)
Figure China Bio-protein Drug Sales Volume Market Share by Type in 2016
Table China Bio-protein Drug Sales Volume (K Units) by Applications (2012-2017)
Table China Bio-protein Drug Sales Volume Market Share by Application (2012-2017)
Figure China Bio-protein Drug Sales Volume Market Share by Application in 2016
Figure Japan Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Bio-protein Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Bio-protein Drug Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Bio-protein Drug Sales Volume (K Units) by Type (2012-2017)
Table Japan Bio-protein Drug Sales Volume Market Share by Type (2012-2017)
Figure Japan Bio-protein Drug Sales Volume Market Share by Type in 2016
Table Japan Bio-protein Drug Sales Volume (K Units) by Applications (2012-2017)
Table Japan Bio-protein Drug Sales Volume Market Share by Application (2012-2017)
Figure Japan Bio-protein Drug Sales Volume Market Share by Application in 2016
Figure South Korea Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea Bio-protein Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Bio-protein Drug Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea Bio-protein Drug Sales Volume (K Units) by Type (2012-2017)
Table South Korea Bio-protein Drug Sales Volume Market Share by Type (2012-2017)
Figure South Korea Bio-protein Drug Sales Volume Market Share by Type in 2016
Table South Korea Bio-protein Drug Sales Volume (K Units) by Applications (2012-2017)
Table South Korea Bio-protein Drug Sales Volume Market Share by Application (2012-2017)
Figure South Korea Bio-protein Drug Sales Volume Market Share by Application in 2016
Figure Taiwan Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan Bio-protein Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Bio-protein Drug Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan Bio-protein Drug Sales Volume (K Units) by Type (2012-2017)
Table Taiwan Bio-protein Drug Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Bio-protein Drug Sales Volume Market Share by Type in 2016
Table Taiwan Bio-protein Drug Sales Volume (K Units) by Applications (2012-2017)
Table Taiwan Bio-protein Drug Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Bio-protein Drug Sales Volume Market Share by Application in 2016
Figure India Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)
Figure India Bio-protein Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Bio-protein Drug Sales Price (USD/Unit) Trend (2012-2017)
Table India Bio-protein Drug Sales Volume (K Units) by Type (2012-2017)
Table India Bio-protein Drug Sales Volume Market Share by Type (2012-2017)
Figure India Bio-protein Drug Sales Volume Market Share by Type in 2016
Table India Bio-protein Drug Sales Volume (K Units) by Application (2012-2017)
Table India Bio-protein Drug Sales Volume Market Share by Application (2012-2017)
Figure India Bio-protein Drug Sales Volume Market Share by Application in 2016
Figure Southeast Asia Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Bio-protein Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Bio-protein Drug Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Bio-protein Drug Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Bio-protein Drug Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Bio-protein Drug Sales Volume Market Share by Type in 2016
Table Southeast Asia Bio-protein Drug Sales Volume (K Units) by Applications (2012-2017)
Table Southeast Asia Bio-protein Drug Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Bio-protein Drug Sales Volume Market Share by Application in 2016
Figure Australia Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Australia Bio-protein Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Bio-protein Drug Sales Price (USD/Unit) Trend (2012-2017)
Table Australia Bio-protein Drug Sales Volume (K Units) by Type (2012-2017)
Table Australia Bio-protein Drug Sales Volume Market Share by Type (2012-2017)
Figure Australia Bio-protein Drug Sales Volume Market Share by Type in 2016
Table Australia Bio-protein Drug Sales Volume (K Units) by Applications (2012-2017)
Table Australia Bio-protein Drug Sales Volume Market Share by Application (2012-2017)
Figure Australia Bio-protein Drug Sales Volume Market Share by Application in 2016
Table Abbott Laboratories Bio-protein Drug Basic Information List
Table Abbott Laboratories Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Abbott Laboratories Bio-protein Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Abbott Laboratories Bio-protein Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Bayer AG Bio-protein Drug Basic Information List
Table Bayer AG Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer AG Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Bayer AG Bio-protein Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Bayer AG Bio-protein Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Eli Lilly and Company Bio-protein Drug Basic Information List
Table Eli Lilly and Company Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Eli Lilly and Company Bio-protein Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Eli Lilly and Company Bio-protein Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Amgen Inc. Bio-protein Drug Basic Information List
Table Amgen Inc. Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Inc. Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Amgen Inc. Bio-protein Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Amgen Inc. Bio-protein Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Biocon Ltd. Bio-protein Drug Basic Information List
Table Biocon Ltd. Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biocon Ltd. Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Biocon Ltd. Bio-protein Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Biocon Ltd. Bio-protein Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Dr. Reddy’s Laboratories Bio-protein Drug Basic Information List
Table Dr. Reddy’s Laboratories Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dr. Reddy’s Laboratories Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Dr. Reddy’s Laboratories Bio-protein Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Dr. Reddy’s Laboratories Bio-protein Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Roche Bio-protein Drug Basic Information List
Table Roche Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Roche Bio-protein Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Roche Bio-protein Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Fresenius kabi Bio-protein Drug Basic Information List
Table Fresenius kabi Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Fresenius kabi Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Fresenius kabi Bio-protein Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Fresenius kabi Bio-protein Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table GlaxoSmithKline Bio-protein Drug Basic Information List
Table GlaxoSmithKline Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Bio-protein Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure GlaxoSmithKline Bio-protein Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Johnson & Johnson Bio-protein Drug Basic Information List
Table Johnson & Johnson Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Johnson & Johnson Bio-protein Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Johnson & Johnson Bio-protein Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Merck Bio-protein Drug Basic Information List
Table Novartis AG Bio-protein Drug Basic Information List
Table Panacea Biotec Bio-protein Drug Basic Information List
Table ProBioGen AG Bio-protein Drug Basic Information List
Table Sanofi Bio-protein Drug Basic Information List
Table Reliance Life Science Pvt. Ltd. Bio-protein Drug Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bio-protein Drug
Figure Manufacturing Process Analysis of Bio-protein Drug
Figure Bio-protein Drug Industrial Chain Analysis
Table Raw Materials Sources of Bio-protein Drug Major Manufacturers in 2016
Table Major Buyers of Bio-protein Drug
Table Distributors/Traders List
Figure Asia-Pacific Bio-protein Drug Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Bio-protein Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Bio-protein Drug Price (USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific Bio-protein Drug Sales Volume (K Units) Forecast by Region (2017-2022)
Figure Asia-Pacific Bio-protein Drug Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Bio-protein Drug Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Bio-protein Drug Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Bio-protein Drug Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Bio-protein Drug Revenue Market Share Forecast by Region in 2022
Figure China Bio-protein Drug Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure China Bio-protein Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Bio-protein Drug Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Bio-protein Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Bio-protein Drug Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure South Korea Bio-protein Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Bio-protein Drug Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan Bio-protein Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Bio-protein Drug Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure India Bio-protein Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Bio-protein Drug Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Bio-protein Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Bio-protein Drug Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Australia Bio-protein Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Bio-protein Drug Sales (K Units) Forecast by Type (2017-2022)
Figure Asia-Pacific Bio-protein Drug Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Bio-protein Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Bio-protein Drug Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Bio-protein Drug Price (USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific Bio-protein Drug Sales (K Units) Forecast by Application (2017-2022)
Figure Asia-Pacific Bio-protein Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications